Mukhtar S Haider, MD 103 Laconia Street Lexington, MA Home: Cell:

Transcription

1 Mukhtar S Haider, MD 103 Laconia Street Lexington, MA Home: Cell: mukhtar-haider@hotmail.com Professional Overview: Seasoned Pharmaceutical business professional with successful track record, with 19 years of Sales, Marketing and General Management experience in several strategic global Pharmaceutical markets including Asia, Europe, South America and United States. This diversified experience includes organizational restructuring, team building, portfolio rationalization and strategy setting, alignment of distribution channels, negotiating business agreements for products, managing Joint Venture, introducing system and procedures for both corporate compliance and robust deliverables. Demonstrated in-depth skills in people management with proven ability to manage cross culturally along with great acumen of cultural sensitivity. Identified and lead strategic change in management, setting measurable objectives for team. Successfully managed the business through economic crises (Asian crisis, 1997, and Turkey, 2001) and maintained the profitability. Experienced in working closely with manufacturing operations for timely product availability and supported in manufacturing process for overall efficiency. Lead the Global full development team, strategically for new product, from early phase 3 planning, and received approval from the senior management on brand strategy based on business opportunity identification and launch plan development. Core competency lies in strong leadership with ability to lead decisively, build result oriented team, have ability to analyze complex business issues, and strategize the outcome. Strong commitment to invest in development of high potential employees through personal coaching, developing through support and exposing to challenging assignments. Mukhtar Haider, CV 1

2 Pharmaceutical Career History: June 08- till to date Full time Management Consultant for Global projects, Bristol-Myers Squibb, Princeton, New Jersey, USA Vice President, Global Commercial Operation Bristol Myers Squibb Medical Imaging, Billerica, MA, USA General Manager Bristol Myers Squibb, Mexico General Manager Bristol Myers Squibb, Korea Vice President & Brand Champion Global Marketing Bristol Myers Squibb, Princeton, New Jersey, USA General Manager Bristol Myers Squibb, Turkey General Manager Bristol Myers Squibb, Indonesia Director Marketing, Sales & Medical Affairs Bristol Myers Squibb Pakistan & Export markets (Bangladesh, Srilanka & Nepal) Medical Director Bristol Myers Squibb Pakistan Clinical Career History: Hospital Appointments / Chest Specialist, Lahore, Pakistan NHS Hospitals in England & Scotland, UK ( 5 years ) Baqai University Hospitals, Karachi, Pakistan (2 yrs ) Mukhtar Haider, CV 2

3 Professional Experience: Management Consultant Bristol-Myers Squibb, Princeton, New Jersey, USA June 2008 till to date Working as a full time management consultant for Bristol Myers Squibb. Projects includes: - Trade Working Capital Projects: Ongoing. Three years plan. - MJN IPO Project. Completed Company wide productivity initiatives. Vice President, Global Commercial Operation, Bristol Myers Squibb, Medical Imaging Billerica, MA Joined Medical Imaging division as Vice President for international business in February 2006 and was promoted to Vice President, Global Commercial Operation in August Responsibilities included global commercial activities for annual revenue of over $650 million. Functions reporting were US Inline Marketing, US Sales and Global marketing responsible for pipe line product and commercialization. International operation reported through business unit which included EU, Latin America and Canada and Asia Pacific. Life cycle management of existing product and budgeting with forecasting. Chairperson for the Marketing Operating committee (MOC) to review the brand plans of the marketed products and commercialization plans of the pipeline products Co-Chair the Research Development Operating Committee (RDOC) with the Vice President of R&D to review and monitor the progress of the clinical programs for the pipeline products. Responsible to review the pre-clinical and clinical data at different stages of development and make appropriate resource investment recommendations to management. Member of the select team to develop strategic options for the Medical Imaging Division as a major product loses its exclusivity by mid Member of the Executive Committee of Medical Imaging Division providing leadership to the organization. Mukhtar Haider, CV 3

4 General Manager Bristol Myers Squibb, Mexico City, Mexico Directly responsible of Pharma business with annual revenue of $260 million, with host responsibility for Mead Johnson & Convatac, with annual revenue of $250 million. Provided support services to 3 manufacturing units for Pharma and Nutritional products. Host services included Finance, Human Resources, Legal and other support function. Inducted a new leadership team committed to highest level of integrity and compliance to BMS business standard. 80% of the operating committee was newly inducted. Reorganized Pharma business into three major business units -mature products, strategic products and OTC portfolio. Prepared new strategic plans and approved reflecting the portfolio shift. Introduced new process and SOPs in order to streamline the decision making and minimized the risk of compliance violations resulting in a clean financial audit in Allowed for strong OTC business performance with improved channel management and effective media campaign with introduction of new advertisement campaigns at prime time. Picot and Tempra were ranked among the top product in their therapeutic class. Implemented a promotional campaign to extend the life cycle of 70 years old mature brand, Penetrexyl, an antibiotic, to improve its profitability and growth. The action plan included launch of new SKU with improved cost. General Manager Bristol Myers Squibb, Seoul, Korea Restructured the leadership team and aligned the organization to newly launched corporate strategy which focused on ten disease areas and high value primary care provider. This included induction of four new members to the operating team and six departmental heads as part of global business synergy. Phase-out approach was used to implement the business unit concept for focus approach and creating synergies and business alignment between sales and marketing. Reviewed product portfolio and completed exit plan for non-profitable products from promotion, resulted in investment in key products and its optimization. Restructured sales force, and improved the coverage of high value customers by right sizing the numbers of sales teams Mukhtar Haider, CV 4

5 Developed and implemented the Taxol defense plan against the low priced generic product, stopped market share erosion, and maintained the leading product position at market place. Successfully managed the co-promotion Plavix through Joint Ventures. Plavix continued a double digit growth and became 3 rd largest product in Korea. Launched HIV product in a niche market with high returns on investment through targeted business planning. Developed in house sales data collection system and implemented to monitor sales representative performance. Important achievement in the absence of reliable third party data. Developed and implemented wholesalers inventory tracking system for effective inventory management which has been highlighted as weakness of the organization. Aggressive Sales and profitability targets were submitted and achieved with endorsement by regional business units. Vice President & Brand Champion Global Marketing Bristol Myers Squibb, Princeton, NJ, USA Global Brand Champion for Entecavir, a new molecule in Phase III for the treatment of chronic Hepatitis B. Responsible for the development of vision, strategies and plans for the successful global commercialization of Entecavir. Worked closely with the Development Champion in PRI (Pharmaceutical institute of Research) for development of clinical program to support the life cycle of the product. Developed Country specific clinical program to focus the special regulatory requirement in China and Japan. Lead the Global Marketing of Entecavir for to define Positioning, Trade name selection, Global Branding, Market Segmentation, Global Pricing and Reimbursement strategy, Publication Plan and pre-launch and Launch plans for key markets. Co-Lead the Full Development team with cross functional representation from clinical, market research, regulatory, technical operation, pricing, global marketing and regional operation. Initiated new business working model by FDT to ensure regional participation in all decision making and was later adopted by all other FDT s. Mukhtar Haider, CV 5

6 Member of the Strategic team responsible to develop/ recommend the Performance Management segment of the Marketing Excellence, a standard tool used by Corporate for all brand planning and discussion. General Manager Bristol Myers Squibb, Istanbul, Turkey Exceeded both sales and profitability targets for both years, turn around of affiliate into profitability. During tenure as General Manager, led continued growth at BMS Turkey confirming the benefits of right sizing and restructuring of the business. Managed the financial crisis of 2001 successfully through timely implementation of system for inventory control and cash collection. BMS Turkey was awarded President s award. Developed a winning leadership team through leadership development and cross functional rotation within the organization. Senior position were filled by high potential candidates from Human Resources, Finance, Medical, Marketing and Sales through this rotational program. Developed and implemented sales forecasting and production planning tool for effective inventory management during high inflation and currency devaluation period. Successfully implemented innovative Taxol defense plans against generic launch and was able to grow the Taxol sales, maintaining profitability despite discounts and commissions. Successfully managed JV relationship to launch Plavix with co promotion partners. Sales of Plavix in Turkey during first twelve months ranked 5 th within BMS worldwide sales behind USA, Germany, France and Spain. Initiated and lead the negotiation with a German company for marketing rights of antiinfective product for Turkey. General Manager Bristol Myers Squibb, Jakarta, Indonesia Mukhtar Haider, CV 6

7 Achieved sales and profitability targets for all the three years despite vibrant business climate due Asian financial crisis and during political crisis. Successfully implemented leadership development programs and exported high quality managers for regional assignment. Three managers were selected for regional expatriate Positions during my tenure as General Manager while two were posted at a later stage. These included two country managers, one regional finance director and one country finance director. Developed and implemented both short term strategy for the business challenge during financial crisis and long term strategy for continued business growth. Negotiated and adopted innovative alternates to avoid any exposures from all distributors when bank guarantees were not available during economic crisis. Used successful business model and timely implementation of strategies, achieved continued growth of the business in Indonesia. Led significant development in order to achieve corporate objective of 100% subsidiary status and delisting of two local listing of stock exchange markets. Successfully conducted and completed all legal requirements of local listing including the General Body Share holders meeting for two years. Participated in key productivity initiatives with Mead Johnson and Technical operations during Asian Financial crisis and achieved Zero complaints status for the host service provided by medicine group. Director Marketing, Sales & Medical Affairs Bristol Myers Squibb & Export markets (Bangladesh, Srilanka & Nepal) Karachi, Pakistan Mukhtar Haider, CV 7

8 Successfully restructured sales and marketing and lead a high performing team which was reflected in the improved IMS ranking of BMS from 15 th in 1988 to 7 th in Re-launched Velosef which became highest ranking product of the industry in Initiated BMS business in Srilanka, Bangladesh and Nepal by getting product registered as import from business by using distributors sales force model. Successfully challenged the regulatory authorities working with corporate legal department for several years against tariff barrier to cephradine raw material import when locally manufactured material became available. Medical Director Bristol Myers Squibb Karachi, Pakistan Developed and established the medical department being the first medical doctor to be appointed. Developed systems and procedure for promotional material review, medical training for sales and marketing and approval of clinical trial approval. Participated in all brand development meeting to provide the medical input to marketing strategies. Supervised all product registration and pricing approval by maintaining a professional and cordial relationship with ministry of health and regulatory agency. Introduced the concept of medical marketing and actively participated in all activities for it successful acceptance by sales and marketing. Assumed marketing responsibilities for cardiovascular franchise in 1991 and successfully launched Capoten for broader indication and usage. Capoten became the fastest growing product of the company despite the availability of low price generic products. Awards, Assignments and other Distinctions: Mukhtar Haider, CV 8

9 1989 Received BMS Business Unit Achievement Q/P Award for BMS Pakistan as a member of the management team. This was the highest award to be given on worldwide basis in Squibb before it merged to become Bristol Myers Squibb Leader of the winning team of BMS Q/P Innovation Award for Repositioning of Velosef in mature market 1993 Member of the Global marketing task force for Capoten and participated in the Development and implementation of Capoten life cycle management plan 1998 Received President s Award for Indonesia on the development of Score Card, a comprehensive tool to monitor the performance of an operation during financial crisis Member of the Global Development Team for Lobucavir, a new molecule for Hepatitis 1999 Received Outstanding Achievement Award for Indonesia for best BUC Achievement versus budget within APMESA region Outstanding Achievement Award for Indonesia for best new OTC TV commercial within APMESA region Received two President s Award for BMS Turkey for Inventory Deployment Team and for Sales Performance Received Outstanding Achievement Award for Turkey for Best Sales Achievement versus budget within APMESA region Received Outstanding Achievement Award for Turkey for Best BUC Achievement versus budget within APMESA region Was selected by BMS to participate in two years ADP (Accelerated Development Development) for high potential manager in executives grades Received President s Award for BMS Turkey for management of Financial Crisis in Turkey 2004 Received Best Performance and Best Growth Achievement award for BMS Korea Received President s award for 'Mature Brand Strategy' and Award of Distinction for Iscover for BMS Mexico Education Background: Mukhtar Haider, CV 9

10 1983 Welsh National School of Medicine, UK DTCD 1978 King Edward Medical College, Pakistan MBBS 1971 Punjab University, Pakistan Bachelor of Arts, Economics Personal Details: Date of Birth: September 1, 1952 Citizenship : USA / Pakistan citizenship Marital Status: Married Mukhtar Haider, CV 10